Index -
P/E -
EPS (ttm) -3.48
Insider Own 0.70%
Shs Outstand 30.30M
Perf Week -3.07%
Market Cap 3.26B
Forward P/E -
EPS next Y -2.08
Insider Trans -7.42%
Shs Float 29.65M
Perf Month -19.94%
Income -104.70M
PEG -
EPS next Q -0.78
Inst Own 105.03%
Short Float / Ratio 7.58% / 6.20
Perf Quarter -4.52%
Sales 430.00M
P/S 7.58
EPS this Y -12.40%
Inst Trans 0.46%
Short Interest 2.25M
Perf Half Y 4.12%
Book/sh 7.32
P/B 13.99
EPS next Y 35.80%
ROA -24.00%
Target Price 153.00
Perf Year -31.36%
Cash/sh 5.54
P/C 18.49
EPS next 5Y -
ROE -44.30%
52W Range 85.74 - 164.69
Perf YTD 9.34%
Dividend -
P/FCF -
EPS past 5Y -24.20%
ROI -41.50%
52W High -37.81%
Beta 1.39
Dividend % -
Quick Ratio 2.90
Sales past 5Y 32.90%
Gross Margin 68.70%
52W Low 19.45%
ATR 5.72
Employees 1793
Current Ratio 3.10
Sales Q/Q 20.60%
Oper. Margin -24.40%
RSI (14) 27.52
Volatility 5.62% 4.88%
Optionable Yes
Debt/Eq 0.00
EPS Q/Q 24.50%
Profit Margin -24.30%
Rel Volume 1.51
Prev Close 101.46
Shortable Yes
LT Debt/Eq 0.16
Earnings May 04 AMC
Payout -
Avg Volume 362.40K
Price 102.42
Recom 1.80
SMA20 -13.91%
SMA50 -18.64%
SMA200 -13.04%
Volume 545,452
Change 0.95%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-07-23 Initiated
Wells Fargo
Overweight
$150
Nov-07-22 Upgrade
Wolfe Research
Underperform → Peer Perform
Jun-09-22 Downgrade
Citigroup
Buy → Neutral
$180 → $155
Apr-06-22 Initiated
Wolfe Research
Underperform
$105
Feb-24-22 Upgrade
Needham
Hold → Buy
$135
Feb-24-22 Upgrade
Needham
Hold → Buy
Jan-18-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$129 → $167
Jan-12-22 Upgrade
BTIG Research
Neutral → Buy
$170
Jan-11-22 Upgrade
Oppenheimer
Perform → Outperform
$150
Dec-21-21 Resumed
Canaccord Genuity
Buy
$125
Dec-17-21 Upgrade
JP Morgan
Neutral → Overweight
$100 → $116
Dec-15-21 Upgrade
Citigroup
Neutral → Buy
$120
Jun-02-21 Downgrade
Citigroup
Buy → Neutral
$105 → $78
Apr-13-21 Downgrade
BTIG Research
Buy → Neutral
Apr-12-21 Downgrade
JP Morgan
Overweight → Neutral
Feb-26-21 Downgrade
Colliers Securities
Buy → Neutral
Jan-29-21 Reiterated
Needham
Hold
Nov-17-20 Downgrade
Oppenheimer
Outperform → Perform
Sep-11-20 Initiated
Needham
Hold
Sep-02-20 Initiated
Robert W. Baird
Neutral
$220
Show Previous Ratings
Jun-06-23 09:00AM
May-27-23 08:28AM
May-24-23 04:05PM
May-22-23 08:30AM
May-11-23 06:09AM
06:05PM
Loading…
May-04-23 06:05PM
04:05PM
Apr-20-23 04:05PM
Apr-14-23 06:51PM
Apr-13-23 12:21PM
Apr-12-23 04:30PM
Apr-02-23 02:07PM
Mar-14-23 07:42AM
Mar-06-23 08:30AM
Mar-02-23 08:30AM
08:04AM
Loading…
Feb-25-23 08:04AM
Feb-24-23 02:44PM
Feb-23-23 04:05PM
Feb-21-23 06:57AM
Feb-09-23 04:05PM
Jan-09-23 08:30AM
Dec-27-22 04:30PM
Dec-01-22 01:54PM
Nov-14-22 10:43AM
Nov-07-22 04:05PM
Nov-06-22 12:30PM
Nov-04-22 11:47AM
Nov-02-22 05:45PM
08:30AM
06:28AM
05:45PM
Loading…
Nov-01-22 05:45PM
04:05PM
Oct-20-22 04:05PM
Sep-21-22 08:30AM
Aug-31-22 08:30AM
Aug-06-22 05:00AM
Aug-05-22 10:27AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 04:30PM
10:02AM
Jul-25-22 04:15PM
Jul-22-22 04:52PM (American City Business Journals)
08:30AM
Jul-18-22 04:10PM
Jul-08-22 08:30AM
Jun-27-22 07:38AM
Jun-19-22 09:03AM
May-25-22 04:05PM
May-06-22 04:11PM (Investor's Business Daily) +5.80%
11:00AM
May-05-22 06:35PM
04:05PM
Apr-28-22 04:05PM
03:02PM
Apr-21-22 04:05PM
Apr-12-22 11:52AM
Apr-03-22 12:35PM
Mar-29-22 04:05PM
Mar-23-22 09:28AM
Mar-14-22 08:30AM
Feb-28-22 12:59PM
12:00PM
Feb-27-22 10:56PM
Feb-23-22 05:25PM
04:05PM
Feb-09-22 04:05PM
Jan-11-22 07:14AM
Jan-10-22 06:29PM
01:19PM
06:25AM
Dec-29-21 04:05PM
Dec-25-21 11:38AM
Dec-11-21 02:43PM
Nov-04-21 08:56PM
04:05PM
Nov-03-21 04:03PM
Nov-02-21 09:37PM
Oct-25-21 02:52PM
Oct-21-21 04:05PM
Oct-12-21 04:05PM
08:17AM
Oct-05-21 04:05PM
Sep-14-21 07:58AM
Sep-13-21 12:58PM
08:15AM
Sep-06-21 01:19PM
01:06PM
Aug-26-21 04:05PM
Aug-05-21 05:55PM
04:05PM
Jul-29-21 04:05PM
03:05PM
Jul-22-21 04:05PM
Jul-21-21 05:17AM
Jul-14-21 06:00AM
03:31AM
Jul-08-21 09:00AM
Jul-06-21 03:52PM
Jun-02-21 08:41AM
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Shrishrimal Sumi EVP, Chief Risk Officer Jun 02 Sale 111.45 1,109 123,598 18,707 Jun 05 04:07 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Mar 29 Sale 125.00 4,000 500,000 35,337 Mar 30 07:32 PM Day Mark J. Chief Technology Officer Mar 03 Sale 117.23 2,116 248,059 54,815 Mar 07 02:06 PM Devine Douglas Chief Operating Officer Mar 03 Sale 117.23 1,473 172,680 29,566 Mar 07 02:02 PM Wilson Daniel G. EVP, Strategy Corp Dev Inv Rel Mar 03 Sale 117.23 1,422 166,701 39,337 Mar 07 02:04 PM Murphy Patrick Michael CLO & EVP RA/QA MrktAcs & Gov Mar 03 Sale 117.23 571 66,938 32,437 Mar 07 02:09 PM Devine Douglas Chief Operating Officer Feb 28 Sale 117.84 3,518 414,563 31,039 Mar 01 06:26 PM Day Mark J. Chief Technology Officer Feb 28 Sale 117.84 1,913 225,431 56,931 Mar 01 06:09 PM Wilson Daniel G. EVP, Strategy Corp Dev Inv Rel Feb 28 Sale 117.84 1,726 203,395 40,759 Mar 01 06:30 PM Murphy Patrick Michael CLO & EVP RA/QA MrktAcs & Gov Dec 02 Sale 106.78 1,704 181,953 23,726 Dec 06 04:37 PM Wilson Daniel G. EVP, Strategy Corp Dev Inv Rel Dec 01 Sale 109.14 1,000 109,140 33,562 Dec 05 04:21 PM Blackford Quentin S. President and CEO Nov 02 Sale 122.40 12,699 1,554,398 89,280 Nov 04 02:20 PM Devine Douglas Chief Operating Officer Sep 29 Sale 125.00 2,000 250,000 27,702 Sep 30 09:31 PM Wilson Daniel G. EVP, Strategy Corp Dev Inv Rel Sep 26 Sale 122.57 3,000 367,716 34,562 Sep 28 11:05 AM Bairey Merz Cathleen Noel Director Sep 12 Sale 159.77 90 14,379 4,887 Sep 14 02:16 PM Devine Douglas Chief Operating Officer & CFO Jul 07 Sale 114.22 10,109 1,154,650 29,702 Jul 11 12:15 PM Wilson Daniel G. EVP, Strategy Corp Dev Inv Rel Jul 05 Sale 108.93 1,428 155,553 37,562 Jul 07 02:01 PM Devine Douglas Chief Operating Officer & CFO Jul 05 Sale 108.90 1,239 134,925 39,811 Jul 07 01:59 PM Bairey Merz Cathleen Noel Director Jun 14 Sale 111.76 500 55,880 4,977 Jun 16 12:50 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite